Krka Logo

Krka

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Krka is a leading global generic pharmaceutical company with over 70 years of experience. Its core business encompasses the development, production, marketing, and sale of high-quality human and animal health products. The company's portfolio is structured into three main segments: prescription pharmaceuticals, non-prescription products for preventing and treating minor illnesses, and a range of animal health products. Krka is committed to quality and innovation in generic medicines, managing the entire value chain from research and development to global distribution to fulfill its mission of 'Living a Healthy Life'.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Krka. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-01 08:30
Regulatory News Service
Detailed report on acquisition of treasury shares
English 131.3 KB
2025-09-01 08:30
Regulatory News Service
Acquisition of treasury shares
English 2.2 KB
2025-09-01 08:30
Regulatory News Service
Podrobno poročilo o nakupih lastnih delnic
Slovene 126.6 KB
2025-09-01 08:30
Regulatory News Service
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-08-25 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 115.2 KB
2025-08-25 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-08-25 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 111.0 KB
2025-08-25 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.1 KB
2025-08-04 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 130.0 KB
2025-08-04 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-08-04 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 129.6 KB
2025-08-04 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.1 KB
2025-07-28 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 124.3 KB
2025-07-28 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.1 KB
2025-07-28 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 121.8 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK